Risk of exposure according to drug formulation
Drug formulation | Potential risk of chronic toxicity through skin contact | Potential risk of acute toxicity through skin contact | Potential risk of chronic toxicity through inhalation | Potential risk of acute toxicity through inhalation | Potential risk of acute toxicity through eyes contact |
---|---|---|---|---|---|
Oral administration | |||||
Uncoated tablets | Yes | Yes | No (except crushed) | No (except crushed) | No (except crushed) |
Coated tablets | No (except crushed) | No (except crushed) | No (except crushed) | No (except crushed) | No (except crushed) |
Capsules | No (except opened) | No (except opened) | No (except opened) | No (except opened) | No (except opened) |
Powder for oral solution | Yes | Yes | Yes | No | No |
Oral solution | Yes | Yes | No | No | No |
Parenteral administration | |||||
Powder for intravenous solution | Yes | Yes | Yes | No | No |
Intravenous solution | Yes | Yes | No | No | No |
Local administration | |||||
Cream, gel | Yes | Yes | No | No | No |
Topic solution | Yes | Yes | Yes | Yes | Yes |
Spray | Yes | Yes | No | No | No |
Solution for inhalation | Yes | Yes | Yes | Yes | Yes |